. 2019 Aug 14;132(3):97–109. doi: 10.1007/s00508-019-1534-1
© The Author(s) 2019
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Fig. 2.
Basic and additional patient assessments before and during ibrutinib therapy